Scholar
IQ
Help
Try ScholarIQ free
Home
Papers
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Upload Records
Snowball Search
Search OpenAlex
About the database
ScholarIQ
answers from OpenAlex
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Paper
Citations, authors & open-access status
3,428
Citations
2,019
Year
bronze
OA Status
IDs:
DOI
PMID
OpenAlex
Related on ScholarIQ
Elizabeth R. Plimack
Author
Michael B. Atkins
Author
New England Journal of Medicine
Journal
Renal cell carcinoma treatment
Topic
Renal cell carcinoma treatment
Topic
Cancer Immunotherapy and Biomarkers
Topic
470M+ articles · free account